1. Home
  2. GLMD vs SOAR Comparison

GLMD vs SOAR Comparison

Compare GLMD & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • SOAR
  • Stock Information
  • Founded
  • GLMD 2000
  • SOAR 2021
  • Country
  • GLMD Israel
  • SOAR United States
  • Employees
  • GLMD N/A
  • SOAR N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • SOAR Blank Checks
  • Sector
  • GLMD Health Care
  • SOAR Finance
  • Exchange
  • GLMD Nasdaq
  • SOAR Nasdaq
  • Market Cap
  • GLMD 8.0M
  • SOAR 9.4M
  • IPO Year
  • GLMD 2014
  • SOAR N/A
  • Fundamental
  • Price
  • GLMD $1.59
  • SOAR $2.02
  • Analyst Decision
  • GLMD Hold
  • SOAR
  • Analyst Count
  • GLMD 1
  • SOAR 0
  • Target Price
  • GLMD N/A
  • SOAR N/A
  • AVG Volume (30 Days)
  • GLMD 81.5K
  • SOAR 1.1M
  • Earning Date
  • GLMD 11-13-2025
  • SOAR 11-17-2025
  • Dividend Yield
  • GLMD N/A
  • SOAR N/A
  • EPS Growth
  • GLMD N/A
  • SOAR N/A
  • EPS
  • GLMD N/A
  • SOAR N/A
  • Revenue
  • GLMD N/A
  • SOAR $96,397,000.00
  • Revenue This Year
  • GLMD N/A
  • SOAR N/A
  • Revenue Next Year
  • GLMD N/A
  • SOAR N/A
  • P/E Ratio
  • GLMD N/A
  • SOAR N/A
  • Revenue Growth
  • GLMD N/A
  • SOAR 309.80
  • 52 Week Low
  • GLMD $1.15
  • SOAR $1.14
  • 52 Week High
  • GLMD $4.81
  • SOAR $19.06
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 58.87
  • SOAR 64.87
  • Support Level
  • GLMD $1.35
  • SOAR $1.70
  • Resistance Level
  • GLMD $1.63
  • SOAR $2.25
  • Average True Range (ATR)
  • GLMD 0.09
  • SOAR 0.18
  • MACD
  • GLMD 0.02
  • SOAR 0.04
  • Stochastic Oscillator
  • GLMD 76.67
  • SOAR 70.55

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About SOAR Volato Group Inc.

Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

Share on Social Networks: